Tag Archives: orphan drug designation

‘1104: New Hope for Eosinophilic Esophagitis Treatment

'1104 offers new hope for eosinophilic esophagitis (EoE) treatment. Promising Phase 2a trial results show.....Read more

Utidelone Receives FDA Orphan Drug Designation for Breast Cancer Brain Metastasis

Utidelone receives FDA orphan drug designation for breast cancer brain metastasis (BCBM). This promising drug.....Read more